Search through all our worldwide HIV and AIDS news and features, using the topics below to filter your results by subjects including HIV treatment, transmission and prevention, and hepatitis and TB co-infections.

Resistance news

Show

From To
Experts raise concerns over high HIV treatment failure in Kenya

Local and international health authorities are concerned about emerging evidence of high HIV treatment failure in Kenya. The latest findings in a report by the Ministry of Health and the UN published last week spoke of "unacceptably" high failure rates of Anti-retrovirals (ARVs) among refugees and residents of Kakuma in northern Kenya.

Published
06 June 2017
From
The Standard
Stock market models accurately predict changes in HIV over time

Stock market models accurately predict changes in HIV over timeHealioMathematical models that were originally developed to predict changes in stock prices accurately predicted changes in the properties of HIV, suggesting that such models could be used for the development of a future vaccine for HIV, according to data published in PLOS Biology.

Published
18 May 2017
From
Healio
Orphan Drug Designation for CytoDyn's PRO 140 Declined by the FDA

Cytodyn has announced that its application for Orphan Drug Designation (ODD) for PRO 140 was not granted by the Office of Orphan Products Development of the U.S. Food and Drug Administration (FDA) because PRO 140 appears to have the potential to treat more than just the subset of multi-drug resistant HIV patients for which the designation was requested.

Published
18 April 2017
From
Cytodyn press release
Case Report of PrEP Failure: What Can We Learn From It?

The New England Journal of Medicine has published the first well-documented case of HIV pre-exposure prophylaxis (PrEP) failure despite good medication adherence. We heard lots of this information at CROI last year, and again I'm impressed at the extraordinary degree of virologic investigation done on a case from clinical practice.

Published
08 February 2017
From
The Body Pro
The Success Of HIV Treatment Is Increasing The Risk Of Drug-Resistance

Global health agencies are succeeding in getting more people with HIV on antiretroviral therapy, a combination of drugs that suppress the virus to undetectable levels in the blood and reduce the risk of transmission to another person. But scientists are beginning to detect a disturbing new trend: The rise of drug-resistant HIV strains, especially in countries such as Kenya, Zambia, Uganda, Nigeria, Tanzania and South Africa.

Published
04 January 2017
From
Huffington Post
Four day a week ART: sub-optimal drug levels but few virological failures

A poster at IAS 2016 reported on the effectiveness of a strategy in France to use reduced dose maintenance therapy. This involved only taking ART for four rather than seven days a week.

Published
20 September 2016
From
HIV i-Base
Think the Aids epidemic is over? Far from it – it could be getting worse

The 2000 Aids conference in Durban shocked the world into action. Now, a new crisis looms, one fuelled by drug resistance, costly treatments and the lack of power many women have in sexual relationships.

Published
31 July 2016
From
The Guardian
Hope for 'end of Aids' is disappearing, experts warn

Those fighting epidemic say 2030 target is unrealistic as efforts to defeat it falter amid rising infection levels and drug resistance.

Published
31 July 2016
From
The Guardian
WHO flags key challenges to global HIV response at International AIDS Conference

The World Health Organization is highlighting the need to renew attention to HIV prevention, whilst maintaining momentum on scaling up access to HIV treatment. It is also signalling the growing emergence of antiretroviral (ARV) drug resistance and the need for sustainable financing of the global response.

Published
17 July 2016
From
WHO
Outbreak of high level azithromycin resistant gonorrhoea in England

There have been 34 cases of high level azithromycin resistant gonorrhoea amongst residents of England between November 2014 and April 2016. The outbreak spread from the north of England to the West Midlands and south of England, including London. Initial cases were among heterosexuals but more recent evidence suggests high level azithromycin resistant gonorrhoea is now spreading among men who have sex with men.

Published
15 April 2016
From
Public Health England
← First12345...7Next →

Filter by country

Community Consensus Statement on Access to HIV Treatment and its Use for Prevention

Together, we can make it happen

We can end HIV soon if people have equal access to HIV drugs as treatment and as PrEP, and have free choice over whether to take them.

Launched today, the Community Consensus Statement is a basic set of principles aimed at making sure that happens.

The Community Consensus Statement is a joint initiative of AVAC, EATG, MSMGF, GNP+, HIV i-Base, the International HIV/AIDS Alliance, ITPC and NAM/aidsmap
close

This content was checked for accuracy at the time it was written. It may have been superseded by more recent developments. NAM recommends checking whether this is the most current information when making decisions that may affect your health.

NAM’s information is intended to support, rather than replace, consultation with a healthcare professional. Talk to your doctor or another member of your healthcare team for advice tailored to your situation.